https://regulatorynews.com/skyrizi-sc-induction-physicians Regulatory News en 2026-10-24T10:49:43-04:00 FDA Approves Subcutaneous-Only Skyrizi Induction https://regulatorynews.com/coreline-soft-aview-aorta-metrics-fda-clearance Regulatory News en 2026-10-24T09:39:51-04:00 Coreline Soft Wins 13th FDA Clearance for Aortic AI https://regulatorynews.com/eko-health-core-300-launch Regulatory News en 2026-10-24T09:39:51-04:00 Eko Health Launches CORE 300 Hybrid AI Stethoscope https://regulatorynews.com/samsung-bioepis-sbe303-fast-track-designation Regulatory News en 2026-10-24T09:39:51-04:00 Samsung Bioepis Earns FDA Fast Track for First ADC https://regulatorynews.com/abbvie-skyrizi-subcutaneous-induction-crohns-approval Regulatory News en 2026-10-24T05:54:27-04:00 FDA Approves At-Home SKYRIZI Start for Crohn's https://regulatorynews.com/edwards-pascal-precision-tricuspid-fda-approval Regulatory News en 2026-10-24T05:54:27-04:00 FDA Clears Edwards' Pascal for Tricuspid Repair https://regulatorynews.com/ema-ama-ebola-vaccine-trial-guidance Regulatory News en 2026-10-24T05:54:27-04:00 EMA, African Regulators Set Rules for Ebola Trials https://regulatorynews.com/pembrolizumab-tmb-h-traditional-approval Regulatory News en 2026-10-23T10:48:10-04:00 FDA Narrows Pembrolizumab's TMB-High Cancer Approval https://regulatorynews.com/altay-therapeutics-dx5057-series-a Regulatory News en 2026-10-23T09:41:32-04:00 Altay Raises $37M for First Oral FSHD Drug https://regulatorynews.com/arrowhead-pharmaceuticals-redemplo-mhra-authorization Regulatory News en 2026-10-23T09:41:32-04:00 Arrowhead Wins UK Nod for Rare-Disease Drug Redemplo https://regulatorynews.com/neuroxt-next-cue-fda-clearance Regulatory News en 2026-10-23T09:41:32-04:00 NeuroXT Clears FDA for Alzheimer's Risk AI Tool https://regulatorynews.com/cardinal-health-presource-bd-alaris-early-alert Regulatory News en 2026-10-23T05:51:08-04:00 FDA Flags Recalled Infusion Sets in Cardinal Kits https://regulatorynews.com/fda-prescription-drug-software-guidance-final Regulatory News en 2026-10-23T05:51:08-04:00 FDA Finalizes Guidance on Drug Companion Apps https://regulatorynews.com/gsk-hibsago-bepirovirsen-hepatitis-b-approval Regulatory News en 2026-10-23T05:51:08-04:00 FDA Approves GSK's Hibsago for Chronic Hepatitis B